Latest Market Access News

CurveBeam AI has received the first A$4 million tranche of a planned A$10 million strategic investment from a leading Chinese orthopaedic device company, marking a significant step in its expansion into the Chinese market.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Australian Bond Exchange Holdings (ABE) has successfully completed live testing in the Reserve Bank of Australia's CBDC pilot, expanded its product offerings, and reported improved cash flow in Q2 FY26.

G50 Corp has initiated core drilling at its Golconda Project amid a sharp rise in gallium, gold, and silver prices, while preparing to drill at White Caps. The company’s upgrade to OTCQX aims to boost U.S. investor access, complemented by recent board changes.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

Medallion Metals has completed a pivotal feasibility study for its Ravensthorpe Gold Project and raised $60 million to accelerate development, while progressing a key acquisition of Forrestania assets.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

Yugo Metals has made promising progress with diamond drilling at its Sinjakovo project, intersecting silver-zinc-lead mineralisation, while securing $3.5 million in new funding and expanding its investor reach through a dual listing in Germany.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Sun Silver Limited has reported a substantial 59 million ounce silver equivalent increase in its Maverick Springs mineral resource, now totalling 539Moz AgEq, alongside commencing U.S. OTCQX trading and appointing a strategic advisor to boost U.S. government engagement.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.